18
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Proviruses with identical sequences comprise a large fraction of the replication-competent HIV reservoir

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The major obstacle to curing HIV infection is the persistence of cells with intact proviruses that can produce replication-competent virus. This HIV reservoir is believed to exist primarily in CD4 + T-cells and is stable despite years of suppressive antiretroviral therapy. A potential mechanism for HIV persistence is clonal expansion of infected cells, but how often such clones carry replication-competent proviruses has been controversial. Here, we used single-genome sequencing to probe for identical HIV sequence matches among viruses recovered in different viral outgrowth cultures and between the sequences of outgrowth viruses and proviral or intracellular HIV RNA sequences in uncultured blood mononuclear cells from eight donors on suppressive ART with diverse proviral populations. All eight donors had viral outgrowth virus that was fully susceptible to their current ART drug regimen. Six of eight donors studied had identical near full-length HIV RNA sequences recovered from different viral outgrowth cultures, and one of the two remaining donors had identical partial viral sequence matches between outgrowth virus and intracellular HIV RNA. These findings provide evidence that clonal expansion of HIV-infected cells is an important mechanism of reservoir persistence that should be targeted to cure HIV infection.

          Author summary

          Antiretroviral therapy (ART) can reduce plasma HIV viral loads to undetectable levels. However, HIV-infected cells can persist despite years of antiretroviral suppression and contribute to rebound viremia following cessation of ART. It is unclear whether HIV-infected cells are maintained by ongoing viral replication, prolonged survival of infected cells, or clonal expansion of infected cells. No studies to date have definitively determined whether clonal expansion is a common mechanism of persistence for replication-competent HIV. To investigate, we used single-genome sequencing to detect identical HIV sequence matches between replication-competent viruses, proviruses, and/or cell-associated RNA from eight donors who were on long-term suppressive ART without evidence of ongoing viral replication. Six of eight donors had identical near full-length sequences between unique replication-competent viruses. One of the two remaining donors had identical partial viral sequences between a replication-competent virus and cell-associated HIV RNA. These findings suggest that clonal expansion is an important mechanism of persistence of replication-competent HIV and should be targeted by HIV cure efforts.

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.

          The hypothesis that quiescent CD4+ T lymphocytes carrying proviral DNA provide a reservoir for human immunodeficiency virus-type 1 (HIV-1) in patients on highly active antiretroviral therapy (HAART) was examined. In a study of 22 patients successfully treated with HAART for up to 30 months, replication-competent virus was routinely recovered from resting CD4+ T lymphocytes. The frequency of resting CD4+ T cells harboring latent HIV-1 was low, 0.2 to 16.4 per 10(6) cells, and, in cross-sectional analysis, did not decrease with increasing time on therapy. The recovered viruses generally did not show mutations associated with resistance to the relevant antiretroviral drugs. This reservoir of nonevolving latent virus in resting CD4+ T cells should be considered in deciding whether to terminate treatment in patients who respond to HAART.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination.

            The development of an effective human immunodeficiency virus type 1 (HIV-1) vaccine is likely to depend on knowledge of circulating variants of genes other than the commonly sequenced gag and env genes. In addition, full-genome data are particularly limited for HIV-1 subtype C, currently the most commonly transmitted subtype in India and worldwide. Likewise, little is known about sequence variation of HIV-1 in India, the country facing the largest burden of HIV worldwide. Therefore, the objective of this study was to clone and characterize the complete genome of HIV-1 from seroconverters infected with subtype C variants in India. Cocultured HIV-1 isolates were obtained from six seroincident individuals from Pune, India, and virtually full-length HIV-1 genomes were amplified, cloned, and sequenced from each. Sequence analysis revealed that five of the six genomes were of subtype C, while one was a mosaic of subtypes A and C, with multiple breakpoints in env, nef, and the 3' long terminal repeat as determined by both maximal chi2 analysis and phylogenetic bootstrapping. Sequences were compared for preservation of known cytotoxic T lymphocyte (CTL) epitopes. Compared with those of the HIV-1LAI sequence, 38% of well-defined CTL epitopes were identical. The proportion of nonconservative substitutions for Env, at 61%, was higher (P < 0.001) than those for Gag (24%), Pol (18%), and Nef (32%). Therefore, characterized CTL epitopes demonstrated substantial differences from subtype B laboratory strains, which were most pronounced in Env. Because these clones were obtained from Indian seroconverters, they are likely to facilitate vaccine-related efforts in India by providing potential antigens for vaccine candidates as well as for assays of vaccine responsiveness.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.

              The capacity of HIV-1 to establish latent infection of CD4+ T cells may allow viral persistence despite immune responses and antiretroviral therapy. Measurements of infectious virus and viral RNA in plasma and of infectious virus, viral DNA and viral messenger RNA species in infected cells all suggest that HIV-1 replication continues throughout the course of infection. Uncertainty remains over what fraction of CD4+ T cells are infected and whether there are latent reservoirs for the virus. We show here that during the asymptomatic phase of infection there is an extremely low total body load of latently infected resting CD4+ T cells with replication-competent integrated provirus (<10(7) cells). The most prevalent form of HIV-1 DNA in resting and activated CD4+ T cells is a full-length, linear, unintegrated form that is not replication competent. The infection progresses even though at any given time in the lymphoid tissues integrated HIV-1 DNA is present in only a minute fraction of the susceptible populations, including resting and activated CD4+ T cells and macrophages.
                Bookmark

                Author and article information

                Contributors
                Role: Editor
                Journal
                PLoS Pathog
                PLoS Pathog
                plos
                plospath
                PLoS Pathogens
                Public Library of Science (San Francisco, CA USA )
                1553-7366
                1553-7374
                22 March 2017
                March 2017
                : 13
                : 3
                : e1006283
                Affiliations
                [1 ]Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, United States of America
                [2 ]Howard Hughes Medical Research Fellows Program, Howard Hughes Medical Institute, Bethesda, Maryland, United States of America
                [3 ]AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research operated by Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America
                [4 ]HIV Dynamics and Replication Program, National Cancer Institute, Frederick, Maryland, United States of America
                [5 ]Advanced Biomedical Computing Center, Frederick National Laboratory for Cancer Research operated by Leidos Biomedical Research, Inc., Frederick, Maryland, United States of America
                [6 ]Department of Molecular Biology and Microbiology, Tufts University, Boston, Massachusetts, United States of America
                University of Illinois at Chicago College of Medicine, UNITED STATES
                Author notes

                JWM is a consultant for Gilead Sciences and a shareholder of Cocrystal Pharma, Inc. WS, BTL, and BFK are employees of Leidos Biomedical Research, Inc. No other authors report competing financial interests.

                • Conceptualization: JKB SHH JMC MFK JWM.

                • Data curation: JKB MDS BFK JS AM WS.

                • Formal analysis: JKB MDS BFK JS AM BTL WS SHH JMC MFK JWM.

                • Funding acquisition: BFK MFK JWM.

                • Investigation: JKB MDS BFK JS AM BTL WS SHH JMC MFK JWM.

                • Methodology: JKB MDS BFK AW BTL WS JMC MFK JWM.

                • Project administration: JKB MDS BFK BTL WS JMC MFK JWM.

                • Resources: JKB MDS BFK JS AM BTL WS MFK JWM.

                • Software: JKB BFK BTL WS MFK JWM.

                • Supervision: JKB MFK JWM.

                • Validation: JKB MDS BFK JS AM AW BTL WS MFK JWM.

                • Visualization: JKB JWM.

                • Writing – original draft: JKB JWM.

                • Writing – review & editing: JKB MDS BFK AW BTL SHH JMC MFK JWM.

                Author information
                http://orcid.org/0000-0001-5905-2049
                http://orcid.org/0000-0002-0470-9880
                http://orcid.org/0000-0002-2777-7376
                Article
                PPATHOGENS-D-17-00211
                10.1371/journal.ppat.1006283
                5378418
                28328934
                4d667dcb-1169-42e0-955f-785b2f821c21

                This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

                History
                : 31 January 2017
                : 8 March 2017
                Page count
                Figures: 2, Tables: 2, Pages: 18
                Funding
                Funded by: funder-id http://dx.doi.org/10.13039/100000054, National Cancer Institute;
                Award ID: HHSN261200800001E
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000054, National Cancer Institute;
                Award ID: HHSN261200800001E
                Award Recipient :
                Funded by: Leidos Biomedical Research, Inc.
                Award ID: 12XS647
                Award Recipient :
                Funded by: Leidos Biomedical Research, Inc.
                Award ID: 13SX110
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000865, Bill and Melinda Gates Foundation;
                Award ID: OPP 115715
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000011, Howard Hughes Medical Institute;
                Award ID: HHMI Medical Research Fellows Program
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000054, National Cancer Institute;
                Award ID: NIH Intramural Program
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000054, National Cancer Institute;
                Award ID: NIH Intramural Program
                Award Recipient :
                Funded by: funder-id http://dx.doi.org/10.13039/100000048, American Cancer Society;
                Award ID: Research Professor of the American Cancer Society
                Award Recipient :
                This work was supported by the National Cancer Institute, National Institutes of Health to BFK and BTL (Contract No. HHSN261200800001E) https://www.cancer.gov/; Leidos Biomedical Research to JWM (Contract No. 12XS647) and to JMC (Contract No. 13SX110) https://www.leidos.com/about/companies/leidos-biomedical-research; and by the Bill & Melinda Gates Foundation (Grant Number: OPP 115715) http://www.gatesfoundation.org/. SHH and MFK were supported by the NIH Intramural Program, Center for Cancer Research, National Cancer Institute; https://www.cancer.gov/. JKB is a Howard Hughes Medical Institute (H.H.M.I.) Medical Research Fellow, http://www.hhmi.org/. JMC is a Research Professor of the American Cancer Society, https://www.cancer.org/. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
                Categories
                Research Article
                Biology and Life Sciences
                Microbiology
                Medical Microbiology
                Microbial Pathogens
                Viral Pathogens
                Immunodeficiency Viruses
                HIV
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Pathogens
                Microbial Pathogens
                Viral Pathogens
                Immunodeficiency Viruses
                HIV
                Biology and Life Sciences
                Organisms
                Viruses
                Viral Pathogens
                Immunodeficiency Viruses
                HIV
                Biology and Life Sciences
                Organisms
                Viruses
                Immunodeficiency Viruses
                HIV
                Biology and life sciences
                Organisms
                Viruses
                RNA viruses
                Retroviruses
                Lentivirus
                HIV
                Biology and Life Sciences
                Microbiology
                Medical Microbiology
                Microbial Pathogens
                Viral Pathogens
                Retroviruses
                Lentivirus
                HIV
                Medicine and Health Sciences
                Pathology and Laboratory Medicine
                Pathogens
                Microbial Pathogens
                Viral Pathogens
                Retroviruses
                Lentivirus
                HIV
                Biology and Life Sciences
                Organisms
                Viruses
                Viral Pathogens
                Retroviruses
                Lentivirus
                HIV
                Biology and Life Sciences
                Microbiology
                Virology
                Viral Replication
                Biology and life sciences
                Molecular biology
                Molecular biology techniques
                Sequencing techniques
                RNA sequencing
                Research and analysis methods
                Molecular biology techniques
                Sequencing techniques
                RNA sequencing
                Biology and Life Sciences
                Cell Biology
                Cellular Types
                Animal Cells
                Blood Cells
                White Blood Cells
                T Cells
                Biology and Life Sciences
                Cell Biology
                Cellular Types
                Animal Cells
                Immune Cells
                White Blood Cells
                T Cells
                Biology and Life Sciences
                Immunology
                Immune Cells
                White Blood Cells
                T Cells
                Medicine and Health Sciences
                Immunology
                Immune Cells
                White Blood Cells
                T Cells
                Research and analysis methods
                Database and informatics methods
                Bioinformatics
                Sequence analysis
                RNA sequence analysis
                Research and Analysis Methods
                Biological Cultures
                Cell Culture Analysis
                Outgrowth Assay
                Research and analysis methods
                Database and informatics methods
                Bioinformatics
                Sequence analysis
                DNA sequence analysis
                Research and analysis methods
                Extraction techniques
                RNA extraction
                Custom metadata
                vor-update-to-uncorrected-proof
                2017-04-03
                The sequences reported in this paper have been deposited in the GenBank database (accession numbers: KY612635-KY612838, KY579951-KY580386, KY552996-KY553110, KY057579-KY058430, KY058677-KY059851, KY748362-KY748654).

                Infectious disease & Microbiology
                Infectious disease & Microbiology

                Comments

                Comment on this article